Pulmonary stenosis is a condition where the valve controlling blood flow from the heart to the lungs becomes too narrow, forcing the heart to work harder to push blood through. It is one of the most common congenital heart defects, present from birth in the majority of cases. Many people with mild narrowing never experience symptoms, while moderate to severe cases can cause noticeable problems during physical activity and, without treatment, lead to lasting heart damage.
How the Valve Normally Works
The pulmonary valve sits between the right ventricle (the lower right chamber of your heart) and the pulmonary artery, which carries oxygen-poor blood to the lungs. Each time the right ventricle contracts, this valve opens to let blood flow through, then closes to prevent it from leaking backward. In pulmonary stenosis, the valve leaflets are thickened, fused together, or otherwise malformed, creating a narrower opening. The right ventricle then has to generate much more pressure to push the same volume of blood through that restricted space.
The narrowing can occur at the valve itself (the most common type), just below the valve in the muscle of the right ventricle, or in the pulmonary artery above the valve. Doctors measure severity by the pressure difference across the valve: mild stenosis involves a gradient below 36 mmHg, moderate falls between 36 and 64 mmHg, and severe exceeds 64 mmHg. That pressure difference reflects how hard the right ventricle is straining to move blood forward.
Causes and Associated Conditions
The vast majority of pulmonary stenosis cases are congenital, meaning the valve develops abnormally during fetal growth. It often occurs in isolation, but it can also appear alongside other structural heart defects. Tetralogy of Fallot, a combination of four heart abnormalities, includes pulmonary stenosis as one of its defining features. Noonan syndrome, a genetic condition that affects growth and heart development, is strongly linked to pulmonary stenosis as well.
Acquired pulmonary stenosis in adults is rare. When it does occur, it is typically related to conditions like carcinoid syndrome (where hormone-producing tumors cause fibrous tissue to build up on heart valves) or, very uncommonly, rheumatic heart disease.
Symptoms by Severity
Many people with mild pulmonary stenosis have no symptoms at all. The condition may go undetected for years until a doctor hears a characteristic whooshing sound (heart murmur) during a routine exam. This murmur is created by blood being forced through the narrowed opening and is one of the earliest detectable signs.
People with more significant narrowing tend to notice symptoms during exercise first. These include shortness of breath, unusual fatigue, chest pain, and in some cases, fainting. Newborns with critical stenosis can appear blue-tinged (cyanotic) because too little blood is reaching the lungs for oxygen exchange. In adults, symptoms often develop gradually as the heart muscle thickens in response to the extra workload, eventually losing its ability to compensate.
How It Is Diagnosed
An echocardiogram is the primary tool for confirming pulmonary stenosis. This ultrasound-based test lets doctors visualize the valve, measure how well it opens, and calculate the pressure gradient across it using Doppler technology. The pressure gradient determines whether the stenosis is mild, moderate, or severe, which directly guides treatment decisions. An electrocardiogram (ECG) can also reveal signs of right ventricular strain, and a chest X-ray may show an enlarged right ventricle or changes in the pulmonary artery.
What Happens Without Treatment
When pulmonary stenosis is mild, many people live normal lives with no intervention beyond periodic monitoring. Moderate and severe cases tell a different story. The right ventricle, which has thinner walls than the left ventricle, is particularly vulnerable to chronic pressure overload. Over time, it responds by thickening its muscle (right ventricular hypertrophy) in an attempt to maintain normal blood output. This adaptation works for a while, but eventually the thickened, stiffened muscle begins to fail.
Once the right ventricle can no longer keep up, it starts to dilate and weaken. Right-sided heart failure develops, causing blood to back up into the body’s venous system. This produces swelling in the legs, fluid buildup in the abdomen, liver enlargement, and progressive fatigue. If still untreated, right-sided failure can eventually compromise the left side of the heart as well, leading to severe, systemic heart failure that significantly reduces quality of life and survival.
Long-term data show that even patients classified as having isolated pulmonary stenosis carry higher mortality risk than the general population, with one large study finding a mortality rate roughly 4.7 times higher than matched controls. This underscores that pulmonary stenosis, while often described as a “benign” heart defect, does require appropriate follow-up.
Balloon Valvuloplasty: The Primary Treatment
For moderate to severe pulmonary stenosis, balloon valvuloplasty is the standard first-line treatment. This is a catheter-based procedure, meaning it does not require open-heart surgery. A thin, flexible tube is threaded through a vein in the groin and guided into the heart. A deflated balloon at the tip of the catheter is positioned inside the narrowed valve and then rapidly inflated to stretch the valve open. The balloon is inflated and deflated several times until the pressure gradient drops to an acceptable level.
Success rates are high. In one study of 60 children, balloon valvuloplasty was successful in 88% of cases, with the average pressure gradient dropping from about 83 mmHg before the procedure to 19 mmHg immediately after, and further declining to around 12 mmHg at long-term follow-up. Only about 4% of patients in that study needed a second procedure for re-stenosis, and re-intervention-free rates held at 96% over the long term.
The procedure is performed under general anesthesia and recovery is relatively quick compared to surgery. Most patients go home within a day or two. For the roughly 10% of cases where balloon valvuloplasty does not achieve adequate results, surgical valvotomy (opening the valve through surgery) becomes the next step.
When Surgery Is Needed
Surgery is reserved for cases where catheter-based treatment is not feasible or has not worked. This includes patients with severely abnormal valve anatomy that a balloon cannot effectively stretch, significant narrowing in the pulmonary artery branches rather than the valve itself, or cases where the valve has been damaged enough to need full replacement. Valve replacement can be done surgically using a bioprosthetic valve or, in some cases, through a transcatheter approach where the new valve is delivered via a catheter similar to the balloon procedure.
The need for valve replacement sometimes arises years after an initially successful treatment. One of the most common long-term complications following any pulmonary valve intervention is pulmonary regurgitation, where the valve no longer closes tightly and blood leaks backward. This affects roughly one-third of patients after valve intervention and can gradually overload the right ventricle with excess blood volume, eventually requiring a replacement valve.
Long-Term Outlook
Event-free survival after valve intervention exceeds 90% over the long term, which means most people who undergo treatment can expect to live active, largely normal lives. Periodic echocardiograms are standard to monitor for re-stenosis or developing regurgitation. People with mild stenosis who never need intervention still benefit from regular check-ups, since the valve can gradually worsen with age in some cases.
Children diagnosed and treated early tend to do especially well, with the right ventricle often remodeling back toward normal thickness once the obstruction is relieved. Adults diagnosed later, particularly those who already have significant right ventricular changes, may have a longer path to full recovery but still see meaningful improvement after successful treatment.